PPA
VRCA icon

Parametric Portfolio Associates’s Verrica Pharmaceuticals VRCA Stock Holding History

Parametric Portfolio Associates’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,247
Closed -$156K – 3703
2021
Q3 		$156K Buy
+1,247
New +$140K ﹤0.01% 3478
2020
Q3 		– Sell
-1,071
Closed -$118K – 3976
2020
Q2 		$118K Buy
+1,071
New +$124K ﹤0.01% 3751

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parametric Portfolio Associates's VRCA Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of Verrica Pharmaceuticals (VRCA) in Q4 2021, closing a stake of 1,247 shares — an estimated $156K sold.

Parametric Portfolio Associates first reported a position in VRCA in Q2 2020 and held it in 2 quarters. The position peaked at $156K in Q3 2021. 45 funds tracked by Wall St. Rank hold VRCA as of Q4 2021.

  • Parametric Portfolio Associates reported no remaining Verrica Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 1,247 Verrica Pharmaceuticals shares in Q4 2021, an estimated $156K.
  • Parametric Portfolio Associates first reported a position in Verrica Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Parametric Portfolio Associates's Verrica Pharmaceuticals position peaked at $156K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.